Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder

Conditions

Premenstrual Dysphoric Disorder

What is the purpose of this trial?

This study will evaluate the effectiveness of sertraline in reducing symptoms in women diagnosed with premenstrual dysphoric disorder.



Participation Guidelines

Age:
18 Years - 48 Years
Gender:
Female

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute of Mental Health (NIMH)
Weill Medical College of Cornell University
Dates:
September 2007
Last Updated:
June 27, 2012
Study HIC#:
0108012595

Clinicaltrials.gov ID: NCT00536198